Diabetes care during COVID: what changed and why it matters
< formatted article >
The Silent Struggle: How COVID-19 Undermined Type 2 Diabetes Care
Before the pandemic, 40% of people with type 2 diabetes were successfully keeping their blood sugar in the safe zone—a feat doctors call "good glycemic control." Achieving this meant maintaining an HbA1c below 7%, a benchmark that drastically reduces the risks of heart disease, vision loss, and kidney damage later in life.
The Pandemic Disruption: A Perfect Storm
When COVID-19 struck, the fragile balance of diabetes management shattered.
- Routine care vanished: Clinics shuttered for deep cleaning, repurposed as testing hubs, or simply became inaccessible as patients feared exposure.
- Telemedicine’s limits: Virtual doctor visits surged, but not everyone could access them. Many lacked smartphones, stable internet, or the digital literacy to navigate these platforms.
- Older adults hit hardest: A majority of diabetes patients are seniors, and for them, the shift to remote care was especially brutal.
At the same time, stress and broken routines sabotaged self-care. Missed meals... abandoned workout plans... emotional eating. Early research revealed a worrying trend: In the pandemic’s first year, the share of patients hitting their HbA1c target dropped by several percentage points.
Wealth vs. Poverty: The Care Divide Widens
This wasn’t just a medical crisis—it was a socioeconomic one.
| Wealthier Neighborhoods | Poorer Areas |
|---|---|
| Doctors had bandwidth for video consultations. | Fewer resources, leading to neglected check-ups. |
| Patients could afford real-time glucose monitors that sent data to clinics. | No glucose monitors—many couldn’t even afford test strips. |
| Stable internet and home setups made remote care feasible. | Crowded housing made it dangerous to step out for supplies. |
| Stronger trust in healthcare systems. | Distrust and barriers delayed or prevented care. |
The Lesson: Diabetes Care Isn’t Just Pills and Payments
The pandemic exposed a harsh truth: Good glycemic control isn’t just about medication. It’s about access—to technology, to trustworthy healthcare, and to the stability that allows healthy habits to thrive.
As we move forward, the question remains: Will we rebuild a system that leaves so many behind… or finally close the gap?
